
An interview with Valérie Philippon: beyond clinical trial data
Valérie Philippon shares her perspectives on the value of including data beyond those generated in clinical trials in publication plans.
A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
Valérie Philippon shares her perspectives on the value of including data beyond those generated in clinical trials in publication plans.
Health literacy expert, Becca Freed, shares her views on why heath literacy is so important and how we can promote clear medical communications for all.
Avishek Pal discusses the development and launch of the ISMPP Authorship Algorithm.
Read Brian Southwell’s perspective on what can be done to prevent misinformation and build public trust in science.
Read about Trishna Bharadia’s experiences with patient collaborations. What has been the impact of COVID-19, and how does she see the future of patient partnerships?
Publication Lead Chris Brooks discusses the impact of COVID-19 on medical communications.
Read Lucy Turner’s perspective on the impact of COVID-19 on medical publications and congresses.
Read Becca Wilson’s perspectives on the current reality and future opportunities for disability inclusivity in medical research and communications.
Read Suzanne Farley’s perspectives on the steps one publisher is taking to address the growing problem of research misconduct.
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.
Data sharing is crucial for reproducibility. Iain Hrynaszkiewicz shares his thoughts on how publishers can promote its uptake.
Sandra Petty discusses the Null Hypothesis Initiative and looks to the future of reporting negative data.
Professor Marcus Munafò discusses the importance of reproducibility in scientific research and how we can overcome barriers to achieving it.
Scientist-turned-filmmaker Randy Olson points to narrative structure as the essential element for clarity and increased audience engagement in scientific communication.
David Mellor from the Center for Open Science explains how the company is supporting and facilitating the open science movement.
Slávka Baróniková shares her opinions on open access publishing and suggests how this can be successfully achieved within pharma.